LATEST ARTICLES

Asciminib (Scemblix) for Newly Diagnosed Chronic Myeloid Leukemia (CML)  

0
Asciminib (Scemblix) has been approved for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). The accelerated approval...

Particle colliders for study of “Very early universe”: Muon collider demonstrated

0
Particle accelerators are used as research tools for the study of very early universe. Hadron colliders (particularly CERN’s Large Hadron Collider LHC) and electron-positron...

De-extinction and Species preservation: New milestones for resurrection of Thylacine (Tasmanian...

0
The thylacine de-extinction project announced in 2022 has achieved new milestones in generation of the highest quality ancient genome, marsupial genome editing and new...

Search of Life Beyond Earth: Clipper Mission to Europa Launched  

0
NASA has successfully launched Clipper mission to Europa into space on Monday 14 October 2024. Two-way communication has been established with the spacecraft since...

Hympavzi (marstacimab): New Treatment for Hemophilia

0
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...

2024 Nobel in Chemistry for “Designing protein” and “Predicting protein structure”...

0
One half of the Nobel Prize in Chemistry 2024 has been awarded to David Baker “for computational protein design”. The other half has been...